Journal article · 2014 · Open access
Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques
Antimicrobial Agents and Chemotherapy, 58(11), 6790–6806 · Published 3 September 2014 · DOI 10.1128/aac.03746-14
In brief
“Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques” is a 2014 journal article by Gregory Q. Del Prete and 23 co-authors, published in Antimicrobial Agents and Chemotherapy. OpenAlex counts 46 citations as of 19 November 2026. It is open access: the full text is free to read at Antimicrobial Agents and Chemotherapy.
- Citations
- 46
- Most cited in
- 2015 (12)
- Field-weighted impact
- 3.79
- References
- 78
- Authors
- 24
Abstract
Nonhuman primate models are needed for evaluations of proposed strategies targeting residual virus that persists in HIV-1-infected individuals receiving suppressive combination antiretroviral therapy (cART). However, relevant nonhuman primate (NHP) models of cART-mediated suppression have proven challenging to develop. We used a novel three-class, six-drug cART regimen to achieve durable 4.0- to 5.5-log reductions in plasma viremia levels and declines in cell-associated viral RNA and DNA in blood and tissues of simian immunodeficiency virus SIVmac239-infected Indian-origin rhesus macaques, then evaluated the impact of treatment with the histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA; Vorinostat) on the residual virus pool. Ex vivo SAHA treatment of CD4(+) T cells obtained from cART-suppressed animals increased histone acetylation and viral RNA levels in culture supernatants. cART-suppressed animals each received 84 total doses of oral SAHA. We observed SAHA dose-dependent increases in acetylated histones with evidence for sustained modulation as well as refractoriness following prolonged administration. In vivo virologic activity was demonstrated based on the ratio of viral RNA to viral DNA in peripheral blood mononuclear cells, a presumptive measure of viral transcription, which significantly increased in SAHA-treated animals. However, residual virus was readily detected at the end of treatment, suggesting that SAHA alone may be insufficient for viral eradication in the setting of suppressive cART. The effects observed were similar to emerging data for repeat-dose SAHA treatment of HIV-infected individuals on cART, demonstrating the feasibility, utility, and relevance of NHP models of cART-mediated suppression for in vivo assessments of AIDS virus functional cure/eradication approaches.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Del Prete, G. Q., Shoemaker, R. S., Oswald, K. A., Lara, A., Trubey, C. M., Fast, R. L., Schneider, D. K., Kiser, R. F., Coalter, V. J., Wiles, A., Wiles, R., Freemire, B. A., Keele, B. F., Estes, J. D., Quiñones, O. A., Smedley, J. V., MacAllister, R., Sánchez, R. I., Wai, J. S. M., . . . Lifson, J. D. (2014). Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques. Antimicrobial Agents and Chemotherapy, 58(11), 6790–6806. https://doi.org/10.1128/aac.03746-14
MLA 9
Del Prete, Gregory Q., et al. “Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques.” Antimicrobial Agents and Chemotherapy, vol. 58, no. 11, 2014, pp. 6790–6806. https://doi.org/10.1128/aac.03746-14.
Chicago
Del Prete, Gregory Q., Rebecca S. Shoemaker, Kelli A. Oswald, Abigail Lara, Charles M. Trubey, Randy L. Fast, Douglas K. Schneider, et al. 2014. “Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques.” Antimicrobial Agents and Chemotherapy 58 (11): 6790–6806. https://doi.org/10.1128/aac.03746-14.
Harvard
Del Prete, G. Q. et al. (2014) ‘Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques’, Antimicrobial Agents and Chemotherapy, 58(11), pp. 6790–6806. doi:10.1128/aac.03746-14.
IEEE
G. Q. Del Prete et al., “Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques,” Antimicrobial Agents and Chemotherapy, vol. 58, no. 11, pp. 6790–6806, 2014, doi: 10.1128/aac.03746-14.
BibTeX
@article{delprete2014effect,
title = {{Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques}},
author = {Del Prete, Gregory Q. and Shoemaker, Rebecca S. and Oswald, Kelli A. and Lara, Abigail and Trubey, Charles M. and Fast, Randy L. and Schneider, Douglas K. and Kiser, Rebecca F. and Coalter, Vicky J. and Wiles, Adam and Wiles, Rodney and Freemire, Brandie A. and Keele, Brandon F. and Estes, Jacob D. and Quiñones, Octavio A. and Smedley, Jeremy V and MacAllister, Rhonda and Sánchez, Rosa I. and Wai, John S. M. and Tan, Christopher M. and Alvord, W. Gregory and Hazuda, Daria J. and Piatak, Michael and Lifson, Jeffrey D.},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2014},
volume = {58},
number = {11},
pages = {6790--6806},
doi = {10.1128/aac.03746-14},
url = {https://doi.org/10.1128/aac.03746-14}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 12 | |
| 2016 | 12 | |
| 2017 | 7 | |
| 2018 | 5 | |
| 2019 | 3 | |
| 2020 | 2 | |
| 2021 | 4 | |
| 2022 | 1 |
Its field-weighted citation impact is 3.79: it has been cited 3.79 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- vorinostat
- histone deacetylase inhibitors
- SIVmac239
- rhesus monkeys
- highly active antiretroviral therapy
- viral suppression
- viral reservoir
- histone acetylation
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Del Prete, G. Q., Shoemaker, R. S., Oswald, K. A., Lara, A., Trubey, C. M., Fast, R. L., Schneider, D. K., Kiser, R. F., Coalter, V. J., Wiles, A., Wiles, R., Freemire, B. A., Keele, B. F., Estes, J. D., Quiñones, O. A., Smedley, J. V., MacAllister, R., Sánchez, R. I., Wai, J. S. M., . . . Lifson, J. D. (2014). Effect of Suberoylanilide Hydroxamic Acid (SAHA) Administration on the Residual Virus Pool in a Model of Combination Antiretroviral Therapy-Mediated Suppression in SIVmac239-Infected Indian Rhesus Macaques. Antimicrobial Agents and Chemotherapy, 58(11), 6790–6806. https://doi.org/10.1128/aac.03746-14
How many times has this paper been cited?
46 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Antimicrobial Agents and Chemotherapy: sign in and open the PDF from this page.
Who wrote this paper?
Gregory Q. Del Prete, Rebecca S. Shoemaker, Kelli A. Oswald, Abigail Lara, Charles M. Trubey, Randy L. Fast, Douglas K. Schneider, Rebecca F. Kiser, Vicky J. Coalter, Adam Wiles, Rodney Wiles, Brandie A. Freemire and 12 more.
What is the DOI of this paper?
10.1128/aac.03746-14, permanently at https://doi.org/10.1128/aac.03746-14. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.